Abstracts tagged "Disparities"

Abstract Number: 0113 • ACR Convergence 2022
Escalation to Biologics After Methotrexate Among US Veterans with Rheumatoid Arthritis Living in Rural versus Urban Areas
Anisha Naik¹, Katherine Wysham², Bryant England³, Punyasha Roul⁴, Michael George⁵, Joshua Baker⁵, Jennifer Barton⁶, Jean Liew⁷, Una Makris⁸, Gail Kerr⁹, Grant Cannon¹⁰, Ted Mikuls¹¹ and Namrata Singh¹², ¹VA Puget Sound, Seattle, WA, ²VA Puget Sound/University of Washington, Seattle, WA, ³University of Nebraska Medical Center, Omaha, NE, ⁴UNMC, Omaha, NE, ⁵University of Pennsylvania, Philadelphia, PA, ⁶VA Portland Health Care System/OHSU, Portland, OR, ⁷Boston University, Boston, MA, ⁸UT Southwestern Medical Center and Dallas VA, Dallas, TX, ⁹Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, ¹⁰Retired, Salt Lake City, UT, ¹¹Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, ¹²University of Washington, Bellevue, WA
Background/Purpose: Timely diagnosis and initiation of appropriate treatments are imperative to improve outcomes for patients with rheumatoid arthritis (RA). Racial and ethnic disparities in RA…
Abstract Number: 0965 • ACR Convergence 2022
Pregnancy Outcomes in a Diverse Lupus Cohort
Julia Simard¹, Emily Liu², Eliza Chakravarty³, Amadeia Rector¹, Miranda Cantu⁴, Daniel Kuo⁵, Gary Shaw⁶, Maurice Druzin⁶, Michael Weisman⁷ and Monique Hedderson², ¹Stanford University School of Medicine, Palo Alto, CA, ²Kaiser Permanente Northern California’s Division of Research, Oakland, CA, ³Oklahoma Medical Research Foundation, Oklahoma City, OK, ⁴Global Lupus Support Group, Portage, MI, ⁵Kaiser Permanente, Redwood City Medical Center, Redwood City, CA, ⁶Stanford University School of Medicine, Palo Alto, ⁷Adjunct Professor of Medicine, Stanford University; Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, Los Angeles, CA
Background/Purpose: Although the overall systemic lupus (SLE) patient population is racially and ethnically diverse, many study populations are homogeneous. We assembled a diverse group of…
Abstract Number: 0091 • ACR Convergence 2022
Association of Area-Level Heat and Social Vulnerability with Recurrent Hospitalizations Among Individuals with Rheumatic Conditions
Leah Santacroce, Paul Dellaripa, Karen Costenbader, Jamie collins and Candace Feldman, Brigham and Women's Hospital, Boston, MA
Background/Purpose: The neighborhood where a person lives influences health behaviors, access, and outcomes, and contributes to disparities. The relationship between susceptibility to the effects of…
Abstract Number: 0114 • ACR Convergence 2022
Addressing Healthcare Disparities Through Implementation of a Medical Student-Based Patient Navigator Program
Grace Shadid¹, Zaid Nakadar¹, Miar Elaskandrany¹, Huchong Cai¹, Alejandra Moncayo¹, Ayten Sergios¹, Marcos Vargas¹, Jeremy Wilson¹, Naureen Kabani², Olga Dvorkina¹ and Ellen M. Ginzler², ¹SUNY Downstate Health Sciences University, Brooklyn, NY, ²SUNY Downstate Health Sciences University, Department of Medicine, Brooklyn, NY
Background/Purpose: African American, Afro-Caribbean, and Hispanic patients diagnosed with rheumatic diseases such as systemic lupus erythematosus (SLE) exhibit more severe disease manifestations compared to white…
Abstract Number: 0973 • ACR Convergence 2022
Assessing Musculoskeletal Health Needs of Underserved Patients & Community Members Using a Community Based Participatory Research Approach
Titilayo Adeniran, Bertilia Trieu, Sandra Goldsmith and Laura Robbins, Hospital for Special Surgery, New York, NY
Background/Purpose: Musculoskeletal disorders are the most prevalent health conditions in the U.S. resulting in financial and social burdens, especially in underserved communities. There are also…
Abstract Number: 0454 • ACR Convergence 2021
Lupus Nephritis Mortality in the United States, 1999-2019: Profound Disparities by Race/Ethnicity and Place of Residence and a Recent Worsening Trend
Eric Yen¹, Snehin Rajkumar¹, Rohan Sharma¹ and Ram Singh², ¹University of California Los Angeles, Los Angeles, CA, ²University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA
Background/Purpose: Mortality from SLE has improved over the last two decades, but remains disproportionately high relative to general population mortality. Lupus nephritis (LN) occurs in…
Abstract Number: 0609 • ACR Convergence 2021
Challenges of Caring for Patients with Inflammatory Arthritis Experiencing Homelessness: Preliminary (12- Month) Follow-up Observations and Identification of Certain Barriers to Care
Baljeet Rai¹, Nicole Zagelbaum Ward², Abhimanyu Amarnani², Corinne Feldman², Brett Feldman² and Richard Panush², ¹LAC+USC Medical Center, Modesto, CA, ²LAC+USC Medical Center, Los Angeles, CA
Background/Purpose: Homelessness is a public health crisis. Those with housing insecurity have unique barriers to healthcare that confound their outcomes. Because of the paucity of…
Abstract Number: 1056 • ACR Convergence 2021
Characterization of the Patterns of Care, Access and Direct Costs of Systemic Lupus Erythematosus in Brazil: Findings from the Macunaíma Study
Mirhelen Mendes de Abreu¹, Vander Fernandes², Odirlei Andre Monticielo³, Alexandre Cristovão Maiorano¹, Fernando dos Santos Beserra¹, Flavia Rachel Moreira Lamarão⁴, Nathalie David⁴, Bruna de Veras⁴, Magda Araujo⁴, Blanca Elena Rios Gomes Bica⁵, Dalianna Luise Andrade Souto Rodrigues², Guilherme Andrade Bulbol⁶, Natalia Jardim Martins da Silva⁷, Domingos Sávio Nunes de Lima⁶ and Marta Maria das Chagas Medeiros⁷, ¹Faculdade de Medicina, Universidade Federal do Rio de Janeiro; MAPEAR Laboratory, Universidade Federal do Rio de Janeiro, Rio De Janeiro, Brazil, ²Universidade de Cuiabá, Cuiabá, Brazil, ³Serviço de Reumatologia do Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, ⁴GlaxoSmithKline, Medical Department, Rio de Janeiro, Brazil, ⁵Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, ⁶Hospital Universitário Getúlio Vargas, Universidade Federal do Amazonas, Manaus, Brazil, ⁷Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil
Background/Purpose: This study evaluated the patterns of care, access and direct costs related to the management and treatment of patients with systemic lupus erythematosus (SLE)…
Abstract Number: 0464 • ACR Convergence 2021
The Impact of Timely Post-Discharge Follow-up on Readmission Risk Among Patients with Systemic Lupus Erythematosus
Maria Schletzbaum¹, Nadia Sweet², W Ryan Powell², Andrea Gilmore Bykovskyi³, Farah Kaiksow², Ann Sheehy², Amy Kind² and Christie Bartels², ¹University of Wisconsin School of Medicine and Public Health, Middleton, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³University of Wisconsin - Madison School of Nursing, Madison, WI
Background/Purpose: Systemic lupus erythematosus (SLE) has the 6th highest hospital readmission rate of all US chronic diseases with significant health disparities and costs. Transitional care…
Abstract Number: 0610 • ACR Convergence 2021
Evaluating Patient No Show Rates to Rheumatology Appointments Across a Regional Healthcare System
Osman Bhatty¹, Rebecca Schorr², Tarun Sharma¹ and Mary Chester Wasko¹, ¹Allegheny Health Network, Pittsburgh, PA, ²Highmark Health, Pittsburgh, PA
Background/Purpose: No-show visits in various clinical settings are costly to providers and to health care systems, potentially representing between 3-14% of a clinic’s yearly income.…
Abstract Number: 1122 • ACR Convergence 2021
Patient-perceived Solutions to the Treatment Barriers in Knee Osteoarthritis: A Qualitative Study from a Diverse Patient Group Including Racial/ethnic Minorities
Jasvinder Singh, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Knee osteoarthritis (OA) has worse outcomes in racial/ethnic minorities. Yet, most of the qualitative studies include primarily Caucasian people with knee OA, with minimal…
Abstract Number: 0492 • ACR Convergence 2021
Racial Differences in Glucocorticoid Use Among Medicaid Beneficiaries with Incident Systemic Lupus Erythematosus
Mia Chandler¹, Leah Santacroce², Karen Costenbader³, Rishi Desai⁴, Seoyoung Kim² and Candace Feldman², ¹Boston Children's Hospital, Brookline, MA, ²Brigham and Women's Hospital, Boston, MA, ³Brigham and Women's Hospital, Belmont, MA, ⁴Brigham and Women's Hospital/Harvard Medical School, Boston, MA
Background/Purpose: Glucocorticoids (GCs) are an integral part of systemic lupus erythematosus (SLE) treatment. Long-term use of GCs is associated with adverse effects. This study evaluated…
Abstract Number: 0611 • ACR Convergence 2021
Association of Area Deprivation Index and Practice Patterns of Medicare Part D Rheumatologists
Shannon Tai¹, Ikechukwu Mbonu² and Michael Putman³, ¹Medical College of Wisconsin, Milwaukee, WI, ²Medical College of Wisconsin, West Allis, WI, ³Medical College of Wisconsin, Brookfield, WI
Background/Purpose: Geographic disparities in the distribution and practice patterns of rheumatology providers may negatively impact patients with rheumatic diseases. The objective of this study was…
Abstract Number: 1168 • ACR Convergence 2021
Barriers to Effectiveness of Non-surgical Treatments for Knee Osteoarthritis in a Diverse Racial/Ethnic Population: A Nominal Group Qualitative Study
Jasvinder Singh, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Knee osteoarthritis (OA) has worse outcome in racial/ethnic minorities, who also have more severe pain, disability and worse outcomes. However, most qualitative studies include…
Abstract Number: 0494 • ACR Convergence 2021
The Distribution of Social Deprivation, Distance to Care and Disease Burden in Rheumatoid Arthritis Patients in the United States
Sharon Dowell¹, Huifeng Yun², Jeffrey Curtis³, Lang Chen⁴, Manuela Pedra-Nobre⁵, Dianne Wollaston⁶, SAWSAN NAJMEY⁷, Cynthia Lawrence-Elliott⁸, Theresa Lawrence-Ford⁹, Heather North¹⁰, Robin Dore¹¹, Soha Dolatabadi¹², Thaila Ramanujam¹³, Anne Winkler¹⁴, Stacy Kennedy¹⁵, Stephanie Ott¹⁶, Stephanie Ledbetter¹⁷, Grace Wright¹⁸ and Gail Kerr¹⁹, ¹Howard University College of Medicine, Washington, DC, ²University of Alabama Birmingham, Birmingham, AL, ³Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Alabama, Birmingham, AL, ⁵North Jersey Rheum. Center, Westfield, NJ, ⁶Memorial Advanced Rheumatology, Houston, TX, ⁷Midstate Rheumatology Center, PA, Freehold, NJ, ⁸North Georgia Rheum Group, Atlanta, GA, ⁹North Georgia Rheum Group, Atlanta, MD, ¹⁰Pardee UNC, Hendersonville, NC, ¹¹Robin K. Dore, MD Inc, Tustin, CA, ¹²Soha Dolatabadi, MD, Los Angeles, CA, ¹³Santa Cruz Rheumatology, Inc., Santa Cruz, CA, ¹⁴Winkler Medical Practice, Springfield, MO, ¹⁵Rowan Diagnostic Clinic, Concord, NC, ¹⁶Fairfield Medical Center, Carroll, OH, ¹⁷University of Alabama at Birmingham, Birmingham, AL, ¹⁸Grace C Wright MD PC, and Association of Women in Rheumatology, New York, NY, ¹⁹Washington D.C., Veterans Affairs Medical Center (VAMC)/Georgetown and Howard Universities, Washington, DC
Background/Purpose: The overall success of RA therapy is dependent on access to specialty care, insurance coverage and effective management of associated comorbidities. Whether RA disease…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].